{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-294013","form_type":"8-K","ticker":"VOR","cik":"0001817229","company_name":"Vor Biopharma Inc.","filed_at":"2022-11-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.285171+00:00","generated_at":"2026-06-21T12:24:15.268069+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"medium","headline":"Vor Biopharma confirms VOR33 engraftment and hematological protection data to be announced later this year","bullets":["Vor Biopharma presented at Piper Sandler 34th Annual Healthcare Conference on November 29, 2022.","Company confirmed upcoming VOR33 data will include engraftment data and hematological protection data.","Data follows treatment with Mylotarg in at least one patient.","VOR33 data expected to be announced later this year."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-294013","json":"https://secwatch.observer/filing/0001193125-22-294013.json","markdown":"https://secwatch.observer/filing/0001193125-22-294013.md","text":"https://secwatch.observer/filing/0001193125-22-294013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1817229/000119312522294013/0001193125-22-294013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1817229/000119312522294013/d426366d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T12:24:15.268069+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}